Information Provided By:
Fly News Breaks for June 30, 2015
ANAC
Jun 30, 2015 | 09:15 EDT
Wedbush believes that sales of Anacor's Kerydin drug have been impressive and could cause the company's Q2 results to beat expectations. The firm significantly raised its 2015-2017 Kerydin sales estimates and keeps an Outperform rating on Anacor.
News For ANAC From the Last 2 Days
There are no results for your query ANAC